Dataset

   File(s) held in another repository
Title of Dataset
Data from: Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System
Author of Dataset
Cheung, Ka-Wai1
Peng, Qiaoli2
He, Liufen2
Cai, Kanru2
Jiang, Qiang2
Zhou, Boping2
To, Sabrina Wai-Chi3
Wang, Hui2
Contact
Chen, Zhiwei1
Wang, Hui2
Date of Dataset Creation
2016-04-19
Description
The development of a rapid, high-throughput and cost-effective HIV-1 drug resistance (HIV-DR) testing system is a challenge for areas consisting different HIV-1 strains. In this study, we established a broadly reactive multiplex assay that could simultaneously detect major drug resistance mutations at 8 loci, which are associated with resistance to commonly used nucleoside reverse transcriptase inhibitors (NRTIs) and Non-nucleoside reverse transcriptase inhibitors (NNRTIs), in specimens of HIV-1 CRF01_AE, CRF07_BC and subtype B, the three major circulating strains in China, using the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) provided by Sequenom MassARRAY® system. To establish the assay, pol gene fragments were prepared from the plasma viral RNA of 159 patients by nested PCR and the presence of wild type and mutant alleles at the 8 loci were analyzed by MALDI-TOF MS. In terms of loci, the detection rate of the alleles was greater than 97% for M41L, K65R, M184V and G190A, 91.2% for K101E/Q/P, 91.2% for T215F/Y, 89.9% for K103N/S and 80.5% for L210W. In terms of individuals, 80% of the alleles were detected in 95.4% CRF01_AE patients, 100% CRF07_BC patients and 83.3% subtype B patients. Importantly, the MALDI-TOF MS results were concordant to the drug resistance profiles of patients obtained from conventional sequencing analysis after excluded the failed detections. Using plasmid templates, the assay was estimated to be sensitive to detect drug resistant variants at level about 20% of the circulating viral population. The capability of this assay to detect mixed viral populations was further verified by two different patient specimens. In conclusion, this study evaluated the use of Sequenom MassARRAY® system for high-throughput detection of HIV-DR mutations towards the commonly used reverse transcriptase inhibitors in China.
Citation
Cheung, KW, Peng, Q, He, L, Cai, K, Jiang, Q, Zhou, B, To, SWC, Yam, WC, Liu, L, Chen, Z, Wang, H. (2016). Data from: Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System. [Data File]. All relevant data are within the paper and its Supporting Information files. Click on “Linked Publications” to access the publication and access supporting information on figshare at https://figshare.com/articles/Rapid_and_Simultaneous_Detection_of_Major_Drug_Resistance_Mutations_in_Reverse_Transcriptase_Gene_for_HIV_1_CRF01_AE_CRF07_BC_and_Subtype_B_in_China_Using_Sequenom_MassARRAY_System/3186271
Subject (RGC Codes)
M2 — Medicine, Dentistry & Health — 醫學, 牙科學及保健
  • 1246 — Drug Discovery and Delivery — 藥物發現與傳遞
Subject (ANZSRC)
11 — MEDICAL AND HEALTH SCIENCES — 醫學與衛生科學
  • 1115 — PHARMACOLOGY AND PHARMACEUTICAL SCIENCES — 藥理學及藥物科學
    • 111502 — Clinical Pharmacology and Therapeutics — 臨床藥理學和治療學
Keyword
Sequenom
drug resistance profiles
215F
MassARRAY
M 41L K 65R M 184V
NNRTI
PCR
detection
CRF
NRTI
8 loci
101E
RNA
pol gene fragments
MS
210W
flight mass spectrometry
allele
Major Drug Resistance Mutations
transcriptase inhibitors
190A
drug resistance mutations
103N
HIV
reactive multiplex assay
Affiliations
  1. Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China ; Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China
  2. Guangdong Med Coll, HKU AIDS Inst Shenzhen Res Lab, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China ; Guangdong Med Coll, AIDS Clin Res Lab, Shenzhen Peoples Hosp 3, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China ; Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China
  3. Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China